{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:07:12Z","timestamp":1762898832451},"reference-count":33,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIAID Division of Intramural Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.vaccine.2012.07.073","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T20:45:29Z","timestamp":1344458729000},"page":"6136-6141","source":"Crossref","is-referenced-by-count":24,"title":["Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein"],"prefix":"10.1016","volume":"30","author":[{"given":"Amy B.","family":"Papaneri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Wirblich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter B.","family":"Jahrling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias J.","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph E.","family":"Blaney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.07.073_bib0005","series-title":"Fields virology","first-page":"1409","article-title":"Filoviridae: Marburg and Ebola viruses","author":"Sanchez","year":"2007"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2012.07.073_bib0010","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/rmv.661","article-title":"Prospects for immunisation against Marburg and Ebola viruses","volume":"20","author":"Geisbert","year":"2010","journal-title":"Rev Med Virol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.07.073_bib0015","doi-asserted-by":"crossref","first-page":"701","DOI":"10.4161\/hv.7.6.15398","article-title":"Filovirus vaccines","volume":"7","author":"Bradfute","year":"2011","journal-title":"Hum Vaccine"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2012.07.073_bib0020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.virol.2010.01.015","article-title":"Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic","volume":"399","author":"Bukreyev","year":"2010","journal-title":"Virology"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.07.073_bib0025","doi-asserted-by":"crossref","first-page":"e1000904","DOI":"10.1371\/journal.ppat.1000904","article-title":"Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebola virus species","volume":"6","author":"Hensley","year":"2010","journal-title":"PLoS Pathog"},{"issue":"January (51)","key":"10.1016\/j.vaccine.2012.07.073_bib0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2008.09.020","article-title":"Protection against lethal challenge by Ebola virus-like particles produced in insect cells","volume":"383","author":"Sun","year":"2009","journal-title":"Virology"},{"issue":"November (Suppl. 2)","key":"10.1016\/j.vaccine.2012.07.073_bib0035","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.1086\/520583","article-title":"Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge","volume":"196","author":"Warfield","year":"2007","journal-title":"J Infect Dis"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.07.073_bib0040","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrmicro2129","article-title":"Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule","volume":"7","author":"Sullivan","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2012.07.073_bib0045","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.1200409109","article-title":"Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease","volume":"109","author":"Dye","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2012.07.073_bib0050","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nm.2447","article-title":"CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates","volume":"17","author":"Sullivan","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2012.07.073_bib0055","doi-asserted-by":"crossref","first-page":"984241","DOI":"10.1155\/2011\/984241","article-title":"Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever","volume":"2011","author":"Warfield","year":"2011","journal-title":"J Biomed Biotechnol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2012.07.073_bib0060","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3390\/v3070982","article-title":"Correlates of immunity to filovirus infection","volume":"3","author":"Bradfute","year":"2011","journal-title":"Viruses"},{"issue":"October (20)","key":"10.1016\/j.vaccine.2012.07.073_bib0065","doi-asserted-by":"crossref","first-page":"10605","DOI":"10.1128\/JVI.00558-11","article-title":"Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses","volume":"85","author":"Blaney","year":"2011","journal-title":"J Virol"},{"issue":"May (Pt 5)","key":"10.1016\/j.vaccine.2012.07.073_bib0070","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1099\/vir.0.80844-0","article-title":"A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies","volume":"86","author":"Faber","year":"2005","journal-title":"J Gen Virol"},{"issue":"December (2)","key":"10.1016\/j.vaccine.2012.07.073_bib0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.vaccine.2009.10.051","article-title":"Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIV(mac251) challenge","volume":"28","author":"Faul","year":"2009","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.07.073_bib0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.77.1.237-244.2003","article-title":"Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic","volume":"77","author":"McGettigan","year":"2003","journal-title":"J Virol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.07.073_bib0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/viro.2001.1212","article-title":"Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines","volume":"292","author":"Siler","year":"2002","journal-title":"Virology"},{"issue":"June (28)","key":"10.1016\/j.vaccine.2012.07.073_bib0090","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1016\/j.vaccine.2011.04.045","article-title":"Immunization of mice with the non-toxic HC50 domain of botulinum neurotoxin presented by rabies virus particles induces a strong immune response affording protection against high-dose botulinum neurotoxin challenge","volume":"29","author":"Mustafa","year":"2011","journal-title":"Vaccine"},{"issue":"December (5805)","key":"10.1016\/j.vaccine.2012.07.073_bib0095","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1126\/science.1133105","article-title":"Ebola outbreak killed 5000 gorillas","volume":"314","author":"Bermejo","year":"2006","journal-title":"Science"},{"issue":"January (5656)","key":"10.1016\/j.vaccine.2012.07.073_bib0100","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.1092528","article-title":"Multiple Ebola virus transmission events and rapid decline of central African wildlife","volume":"303","author":"Leroy","year":"2004","journal-title":"Science"},{"issue":"Junuary (92)","key":"10.1016\/j.vaccine.2012.07.073_bib0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0378-1119(95)00149-Z","article-title":"Selection of recombinant vaccinia viruses on the basis of plaque formation","volume":"158","author":"Blasco","year":"1995","journal-title":"Gene"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2012.07.073_bib0110","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1128\/JVI.01870-09","article-title":"Characterization of a single-cycle rabies virus-based vaccine vector","volume":"84","author":"Gomme","year":"2010","journal-title":"J Virol"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2012.07.073_bib0115","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/bsp.2011.0051","article-title":"Evaluation of perceived threat differences posed by filovirus variants","volume":"9","author":"Kuhn","year":"2011","journal-title":"Biosecur Bioterror"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2012.07.073_bib0120","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.virol.2008.09.030","article-title":"Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge","volume":"383","author":"Bukreyev","year":"2009","journal-title":"Virology"},{"issue":"December (1)","key":"10.1016\/j.vaccine.2012.07.073_bib0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.vaccine.2010.10.024","article-title":"Respiratory tract immunization of non-human primates with a newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response","volume":"29","author":"DiNapoli","year":"2010","journal-title":"Vaccine"},{"issue":"August (6949)","key":"10.1016\/j.vaccine.2012.07.073_bib0130","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01876","article-title":"Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates","volume":"424","author":"Sullivan","year":"2003","journal-title":"Nature"},{"issue":"November (6812)","key":"10.1016\/j.vaccine.2012.07.073_bib0135","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/35046108","article-title":"Development of a preventive vaccine for Ebola virus infection in primates","volume":"408","author":"Sullivan","year":"2000","journal-title":"Nature"},{"issue":"December (26)","key":"10.1016\/j.vaccine.2012.07.073_bib0140","doi-asserted-by":"crossref","first-page":"15889","DOI":"10.1073\/pnas.2237038100","article-title":"Ebola virus-like particles protect from lethal Ebola virus infection","volume":"100","author":"Warfield","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"November (Suppl. 2)","key":"10.1016\/j.vaccine.2012.07.073_bib0145","doi-asserted-by":"crossref","first-page":"S404","DOI":"10.1086\/520591","article-title":"Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever","volume":"196","author":"Jones","year":"2007","journal-title":"J Infect Dis"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2012.07.073_bib0150","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4049\/jimmunol.175.2.1184","article-title":"Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection","volume":"175","author":"Warfield","year":"2005","journal-title":"J Immunol"},{"issue":"July (14)","key":"10.1016\/j.vaccine.2012.07.073_bib0155","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1128\/JVI.00561-09","article-title":"Single injection vaccine protects nonhuman primates against Marburg virus and three species of Ebola virus","volume":"83","author":"Geisbert","year":"2009","journal-title":"J Virol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.07.073_bib0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrmicro2260","article-title":"The cell biology of rabies virus: using stealth to reach the brain","volume":"8","author":"Schnell","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.07.073_bib0165","first-page":"304","article-title":"Estimating human rabies mortality in the United Republic of Tanzania from dog bite injuries","volume":"80","author":"Cleaveland","year":"2002","journal-title":"Bull World Health Organ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12011085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12011085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T13:24:06Z","timestamp":1562073846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12011085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":33,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0264410X12011085"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.07.073","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}